Data / Form D filings / Stingray Therapeutics, Inc.
Stingray Therapeutics, Inc.: Form D filings
Stingray Therapeutics, Inc., a biotechnology company in Dallas, TX, filed 7 Form D notices with the SEC between 2020 and 2024. The latest, on May 14, 2024, reports $25,000 sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- HEALTH WILDCATTERS INCUBATOR, 3000 PEGASUS PARK DR., SUITE 1330, Dallas, TX, 75247
- Phone
- (317) 517-9500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1759143
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2024 | New notice | $5,000,000 | $25,000 | $4,975,000 | 1 | May 1, 2024 | sec.gov |
| Feb 2, 2024 | New notice | $450,000 | $436,758 | $13,242 | 21 | Dec 19, 2023 | sec.gov |
| Dec 28, 2023 | Amendment | $6,668,926 | $6,612,080 | $56,846 | 52 | Jan 23, 2023 | sec.gov |
| Mar 31, 2023 | New notice | $5,230,297 | $3,948,445 | $1,281,852 | 43 | Jan 23, 2023 | sec.gov |
| May 26, 2021 | Amendment | $3,000,000 | $1,510,272 | $1,489,728 | 9 | Jul 31, 2020 | sec.gov |
| Oct 13, 2020 | Amendment | $1,500,000 | $117,272 | $1,382,728 | 6 | Jul 31, 2020 | sec.gov |
| Aug 13, 2020 | New notice | $1,500,000 | $52,272 | $1,447,728 | 2 | Jul 31, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan P. Northrup | Executive Officer, Director | |
| Sunil P. Sharma | Executive Officer, Director | |
| Uma P. Bhatt | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of May 13, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Stingray Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.